Back to Trades
Yaacov-Garbeli Dana
Chief Financial OfficerCIK 0001909822
Largest Purchase
No open-market purchases in the recent filings.
Profile
- Filings
- 2
- Buy transactions
- 0
- Sell transactions
- 0
- Companies
- 1
- Active
- 2025–2026
Across 2 filings between 2025–2026, Yaacov-Garbeli Dana, Chief Financial Officer, has disclosed $296.4K in transactions — all concentrated in Entera Bio Ltd. (ENTX). Data is sourced from official SEC Form 3, 4, and 5 filings.
Associated Companies
Trading History
2 loaded
| May 8 | ENTX Entera Bio Ltd. | Yaacov-Garbeli Dana | Chief Financial Officer | Grant | $0 |
| Jul 18 | ENTX Entera Bio Ltd. | Yaacov-Garbeli Dana | Chief Financial Officer | Grant | $296.4K |
2 filings